Mirabella Financial Services LLP increased its stake in shares of AMETEK, Inc. (NYSE:AME – Free Report) by 118.0% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,494 shares of the technology company’s stock after purchasing an additional 7,846 shares during the quarter. Mirabella Financial Services LLP’s holdings in AMETEK were worth $2,720,000 at the end of the most recent quarter.
A number of other hedge funds also recently bought and sold shares of AME. Vanguard Group Inc. grew its position in shares of AMETEK by 0.7% during the third quarter. Vanguard Group Inc. now owns 27,173,705 shares of the technology company’s stock worth $5,108,657,000 after buying an additional 176,040 shares in the last quarter. State Street Corp raised its holdings in AMETEK by 1.3% in the third quarter. State Street Corp now owns 9,763,684 shares of the technology company’s stock valued at $1,835,573,000 after acquiring an additional 126,381 shares in the last quarter. Invesco Ltd. lifted its stake in AMETEK by 4.9% in the third quarter. Invesco Ltd. now owns 4,463,518 shares of the technology company’s stock worth $839,141,000 after acquiring an additional 209,043 shares during the last quarter. Norges Bank purchased a new position in AMETEK in the second quarter worth approximately $650,613,000. Finally, EdgePoint Investment Group Inc. grew its holdings in AMETEK by 24.4% during the 2nd quarter. EdgePoint Investment Group Inc. now owns 2,926,530 shares of the technology company’s stock worth $529,585,000 after acquiring an additional 573,191 shares in the last quarter. Institutional investors and hedge funds own 87.43% of the company’s stock.
Analysts Set New Price Targets
A number of equities research analysts have recently weighed in on the stock. Morgan Stanley raised their price objective on shares of AMETEK from $215.00 to $235.00 and gave the company an “equal weight” rating in a report on Thursday, March 12th. Melius Research set a $235.00 target price on shares of AMETEK in a research note on Monday, January 5th. Mizuho set a $235.00 target price on AMETEK in a report on Wednesday, February 4th. Weiss Ratings restated a “buy (b)” rating on shares of AMETEK in a research note on Wednesday, January 21st. Finally, Deutsche Bank Aktiengesellschaft assumed coverage on AMETEK in a research report on Wednesday, January 21st. They set a “buy” rating and a $271.00 price objective for the company. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $244.82.
Insider Buying and Selling at AMETEK
In other news, VP Thomas M. Montgomery sold 6,388 shares of the business’s stock in a transaction dated Monday, December 22nd. The stock was sold at an average price of $205.05, for a total value of $1,309,859.40. Following the completion of the sale, the vice president directly owned 22,116 shares of the company’s stock, valued at approximately $4,534,885.80. The trade was a 22.41% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.57% of the company’s stock.
AMETEK Trading Down 1.4%
Shares of AMETEK stock opened at $212.47 on Thursday. The company has a current ratio of 1.06, a quick ratio of 0.67 and a debt-to-equity ratio of 0.10. The company has a fifty day simple moving average of $224.88 and a 200-day simple moving average of $204.70. The stock has a market cap of $48.67 billion, a price-to-earnings ratio of 33.20, a PEG ratio of 3.08 and a beta of 1.02. AMETEK, Inc. has a 12-month low of $145.02 and a 12-month high of $242.05.
AMETEK (NYSE:AME – Get Free Report) last announced its quarterly earnings results on Tuesday, February 3rd. The technology company reported $2.01 EPS for the quarter, topping the consensus estimate of $1.94 by $0.07. AMETEK had a net margin of 20.00% and a return on equity of 16.55%. The firm had revenue of $2 billion for the quarter, compared to analyst estimates of $1.94 billion. During the same period last year, the business earned $1.87 EPS. AMETEK’s revenue for the quarter was up 13.4% compared to the same quarter last year. AMETEK has set its Q1 2026 guidance at 1.850-1.900 EPS and its FY 2026 guidance at 7.870-8.070 EPS. On average, equities analysts forecast that AMETEK, Inc. will post 7.15 EPS for the current fiscal year.
AMETEK Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Monday, March 16th will be given a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.6%. This is an increase from AMETEK’s previous quarterly dividend of $0.31. The ex-dividend date is Monday, March 16th. AMETEK’s payout ratio is presently 21.25%.
AMETEK Profile
AMETEK, Inc is a global manufacturer of electronic instruments and electromechanical devices that serves a broad range of industries. Headquartered in Berwyn, Pennsylvania, the company designs and produces precision instruments, electronic measurement devices, specialty sensors, and electric motors and motion control systems. Its product portfolio includes analytical and monitoring instruments, calibration equipment, power supplies, embedded electronics, and industrial motors and drives used for critical applications.
The company operates through two primary business platforms — an electronic instruments group focused on analytical, test and measurement and sensor products, and an electromechanical group that supplies motors, actuators, and related power and motion solutions.
Featured Stories
Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.
